Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06339320 · ClinicalTrials.gov registry record · NA
Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity
A NA study of Obesity and Endoscopic Sleeve Gastroplasty, sponsored by The Methodist Hospital Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT06339320 is a NA study of Obesity and Endoscopic Sleeve Gastroplasty that is actively recruiting participants, run by The Methodist Hospital Research Institute. The registered enrollment target is 150 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06339320, a NA study of Obesity and Endoscopic Sleeve Gastroplasty, is actively recruiting participants, sponsored by The Methodist Hospital Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate endoscopic sleeve gastroplasty (ESG) for the treatment of obesity. The ESG procedure is an U.S. Food and Drug Administration (FDA) approved procedure for the treatment of obesity - patients with a body mass index (BMI) 30-50 kg/m2. This procedure is FDA approved; however, Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP)-Accredited centers (such as Houston Methodist Hospital) must receive approval from an Institutional Review Board (IRB) in order to perform primary procedures, such as ESG, that are not endorsed by the American Society for Metabolic and Bariatric Surgery (ASMBS).
Conditions Studied
Interventions
- PROCEDURE Endoscopic Sleeve Gastroplasty (ESG)
- DEVICE Apollo OverStitch endoscopic suturing device
Study Locations (2)
Texas
- Houston Methodist Hospital - Houston
- Houston Methodist Hospital - Sugarland - Sugar Land
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-02-28 |
| Est. Completion | 2033-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06339320
The ClinicalTrials.gov registry entry for NCT06339320 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (82% lower). The listed sponsor is The Methodist Hospital Research Institute, which has 126 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Endoscopic Sleeve Gastroplasty (ESG) is the first listed.
NCT06339320 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06339320 about?
NCT06339320 is a clinical study titled "Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity". The purpose of this study is to evaluate endoscopic sleeve gastroplasty (ESG) for the treatment of obesity. The ESG procedure is an U.S. Food and Drug Administration (FDA) approved procedure for the treatment of obesity - patients with a body mass index (BMI) 30-50 kg/m2. This procedure is FDA appro...
What is the current status of trial NCT06339320?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-02-28. Estimated completion is 2033-10.
What conditions does trial NCT06339320 study?
This clinical trial studies the following conditions: Obesity, Endoscopic Sleeve Gastroplasty.
What interventions are being tested in trial NCT06339320?
The interventions under investigation include: Endoscopic Sleeve Gastroplasty (ESG) (PROCEDURE), Apollo OverStitch endoscopic suturing device (DEVICE).
Who is sponsoring clinical trial NCT06339320?
This trial is sponsored by The Methodist Hospital Research Institute, which has 126 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06339320 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.